Intracoronary autologous bone marrow cell transfer after myocardial infarction: The BOOST-2 randomised placebo-controlled clinical trial

European Heart Journal

Volumn 38, Issue 39, 2017, Pages 2936-2943

  Wollert, Kai C ^a   Meyer, Gerd P ^a   Müller Ehmsen, Jochen ^b   Tschöpe, Carsten ^c   Bonarjee, Vernon ^d   Larsen, Alf Inge ^d   May, Andreas E ^e   Empen, Klaus ^f   Chorianopoulos, Emmanuel ^g   Tebbe, Ulrich ^h   Waltenberger, Johannes ⁱ   Mahrholdt, Heiko ^j   Ritter, Benedikta ^a   Pirr, Jens ^a   Fischer, Dieter ^a   Korf Klingebiel, Mortimer ^a   Arseniev, Lubomir ^a   Heuft, Hans Gert ^a   Brinchmann, Jan E ^k   Messinger, Diethelm ^l   Hertenstein, Bernd ^a   Ganser, Arnold ^a   Katus, Hugo A ^g   Felix, Stephan B ^f   Gawaz, Meinrad P ^e   Dickstein, Kenneth ^d   Schultheiss, Heinz Peter ^c   Ladage, Dennis ^b   Greulich, Simon ^j   Bauersachs, Johann ^a   more..

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF BERGEN   (Norway)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h Lippe Detmold Hospital   (Germany)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

^j ROBERT BOSCH HOSPITAL   (Germany)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l Professional Medical Trials and Information System (Prometris)   (Germany)

more..

Author keywords

Bone marrow cell therapy; Cardiac magnetic resonance imaging; Randomized placebo controlled trial; ST segment elevation myocardial infarction

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL TRANSFER; CELL VIABILITY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GAMMA IRRADIATION; GROIN HEMATOMA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AUTOTRANSPLANTATION; BONE MARROW CELL; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; GAMMA RADIATION; HEART LEFT VENTRICLE FUNCTION; INTRALESIONAL DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MULTICENTER STUDY; PHYSIOLOGY; PROCEDURES; RADIATION RESPONSE; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; GAMMA RAYS; HUMANS; INFUSIONS, INTRALESIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; ST ELEVATION MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 85030419983     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehx188     Document Type: Article

References (22)

1. Bagai A, Dangas GD, Stone GW, Granger CB. Reperfusion strategies in acute coronary syndromes. Circ Res 2014;114:1918-1928.
2. Shah RV, Holmes D, Anderson M, Wang TY, Kontos MC, Wiviott SD, Scirica BM. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry. Circ Heart Fail 2012;5:693-702.
3. Mamas MA, Anderson SG, O'kane PD, Keavney B, Nolan J, Oldroyd KG, Perera D, Redwood S, Zaman A, Ludman PF, de Belder MA; on behalf of the British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research. Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society. Eur Heart J 2014;35:3004-3012.
4. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 'T Hof A, Widimsky P, Zahger D. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
5. Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 2010;7:204-215.
6. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148.
7. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209.
8. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. for the REPAIR-AMI investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
9. Huikuri HV, Kervinen K, Niemela M, Ylitalo K, Saily M, Koistinen P, Savolainen ER, Ukkonen H, Pietila M, Airaksinen JK, Knuuti J, Makikallio TH; for the FINCELL investigators. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008;29:2723-2732.
10. Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Piek JJ, Zijlstra F; on behalf of the HEBE investigators. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 2011;32:1736-1747.
11. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; for the Cardiovascular Cell Therapy Research Network (CCTRN). Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 2011;306:2110-2119.
12. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; for the Cardiovascular Cell Therapy Research Network (CCTRN). Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 2012;308:2380-2389.
13. Sürder D, Manka R, Lo Cicero V, Moccetti T, Rufibach K, Soncin S, Turchetto L, Radrizzani M, Astori G, Schwitter J, Erne P, Zuber M, Auf der Maur C, Jamshidi P, Gaemperli O, Windecker S, Moschovitis A, Wahl A, Bühler I, Wyss C, Kozerke S, Landmesser U, Lüscher TF, Corti R. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation 2013;127:1968-1979.
14. Choudry F, Hamshere S, Saunders N, Veerapen J, Bavnbek K, Knight C, Pellerin D, Locca D, Westwood M, Rakhit R, Crake T, Kastrup J, Parmar M, Agrawal S, Jones D, Martin J, Mathur A. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial. Eur Heart J 2016;37:256-263.
15. Fisher SA, Zhang H, Doree C, Mathur A, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2015;9:doi:10.1002/ 14651858.CD006536.pub4.
16. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction. Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113:1287-1294.
17. van Berlo JH, Molkentin JD. An emerging consensus on cardiac regeneration. Nat Med 2014;20:1386-1393.
18. Hodgkinson CP, Bareja A, Gomez JA, Dzau VJ. Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circ Res 2016;118:95-107.
19. Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, Meyer GP, Ganser A, Drexler H, Wollert KC. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008;29:2851-2858.
20. Korf-Klingebiel M, Reboll MR, Klede S, Brod T, Pich A, Polten F, Napp LC, Bauersachs J, Ganser A, Brinkmann E, Reimann I, Kempf T, Niessen HW, Mizrahi J, Schö nfeld HJ, Iglesias A, Bobadilla M, Wang Y, Wollert KC. Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat Med 2015;21:140-149.
21. Treleaven J, Gennery A, Marsh J, Norfolk D, Page L, Parker A, Saran F, Thurston J, Webb D. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br J Haematol 2011;152:35-51.
22. Griesel C, Heuft HG, Herrmann D, Franke A, Ladas D, Stiehler N, Stucki A, Braun M, Wollert KC, Meyer GP, Drexler H, Hertenstein B, Ganser A, Rüdinger W, Arseniev L. Good manufacturing practice-compliant validation and preparation of BM cells for the therapy of acute myocardial infarction. Cytotherapy 2007;9:35-43.